Omicron booster vaccine reduces COVID hospitalization, death in elderly
Clalit study is the first in the world to prove new reformulated Omicron vaccine protects the elderly and immunocompromised from hospitalization and death.
Stay updated with breaking news from Clalit Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clalit study is the first in the world to prove new reformulated Omicron vaccine protects the elderly and immunocompromised from hospitalization and death.
Effectively collaborating with computers could help reduce errors and allow healthcare to shift from supplying patient-level, reactive therapeutics to predictive, proactive and preventative care.
The mission is being organised by Australian not-for-profit AUSiMED, which fosters collaborative biomedical research and knowledge exchange between world-leading clinicians and scientists in Australia and Israel.
Clalit will use the Lynx MD platform to enable research and development by sharing anonymized medical data securely.
/PRNewswire/ -- Lynx MD and Clalit Health Services, the largest provider of public and semi-private health services in Israel, today announced a partnership to...